Company Logo
US NY Suffolk County Shirley Agricultural Biotechnology

mogalizumab

Agricultural Biotechnology

Updated on Feb 10, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for mogalizumab with ID of: 4041033
Recombinant monoclonal antibody to CCR4. Mogamulizumab (USAN; trade name Poteligeo) is a humanized monoclonal antibody targeting CC chemokine receptor 4 (CCR4). It has been approved in Japan for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma.
View all posts by Bella SmithIs this your business? Claim this post.Contact Bella Smith
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.